VI.v
Foreign body/substance pulmonary embolism
Causative drugs
10
Cement (bone cement, kyphoplasty, vertebroplasty)
II.b
II - Pulmonary edema - Acute lung injury - ARDS
II.b - ARDS - Acute lung injury V.n V - Pleural and/or pericardial involvement
V.n - Hemopericardium - Bloody pericardial effusion VI.e VI - Pulmonary vasculopathies
VI.e - Fat/oil embolism - The FES embolism syndrome VI.h VI - Pulmonary vasculopathies
VI.h - Cement embolism VI.t VI - Pulmonary vasculopathies
VI.t - Pulmonary artery aneurysm(s) VI.v VI - Pulmonary vasculopathies
VI.v - Foreign body/substance pulmonary embolism X.f X - Systemic/Distant conditions, syndromes and reactions
X.f - Anaphylaxis-Anaphylactoid reaction (can be fatal) XII.ao XII - Cardiovascular involvement / toxicity
XII.ao - Intracardiac bone cement embolism XII.bd XII - Cardiovascular involvement / toxicity
XII.bd - Perforation of the heart - Cardiac rupture XV.ae XV - Pathology
XV.ae - Path: Lipid/fat embolism (see also VIe) XV.ai XV - Pathology
XV.ai - Path: Acrylate bone cement pulmonary embolism XVI.ax XVI - Imaging
XVI.ax - Imaging: Foreign body pulmonary embolism XVIII.g XVIII - Distinctive patterns - 'Eye-catchers'
XVIII.g - Eye-catcher: Cement (pulmonary) embolism
II.b - ARDS - Acute lung injury V.n V - Pleural and/or pericardial involvement
V.n - Hemopericardium - Bloody pericardial effusion VI.e VI - Pulmonary vasculopathies
VI.e - Fat/oil embolism - The FES embolism syndrome VI.h VI - Pulmonary vasculopathies
VI.h - Cement embolism VI.t VI - Pulmonary vasculopathies
VI.t - Pulmonary artery aneurysm(s) VI.v VI - Pulmonary vasculopathies
VI.v - Foreign body/substance pulmonary embolism X.f X - Systemic/Distant conditions, syndromes and reactions
X.f - Anaphylaxis-Anaphylactoid reaction (can be fatal) XII.ao XII - Cardiovascular involvement / toxicity
XII.ao - Intracardiac bone cement embolism XII.bd XII - Cardiovascular involvement / toxicity
XII.bd - Perforation of the heart - Cardiac rupture XV.ae XV - Pathology
XV.ae - Path: Lipid/fat embolism (see also VIe) XV.ai XV - Pathology
XV.ai - Path: Acrylate bone cement pulmonary embolism XVI.ax XVI - Imaging
XVI.ax - Imaging: Foreign body pulmonary embolism XVIII.g XVIII - Distinctive patterns - 'Eye-catchers'
XVIII.g - Eye-catcher: Cement (pulmonary) embolism
4
Cyanoacrylate (N-butyl-2-cyanoacrylate-Histoacryl)
II.b
II - Pulmonary edema - Acute lung injury - ARDS
II.b - ARDS - Acute lung injury V.b V - Pleural and/or pericardial involvement
V.b - Eosinophilic pleural effusion VI.h VI - Pulmonary vasculopathies
VI.h - Cement embolism VI.v VI - Pulmonary vasculopathies
VI.v - Foreign body/substance pulmonary embolism XI.b XI - Miscellaneous
XI.b - Chest pain (acute or subacute), lone or prominent XVIII.g XVIII - Distinctive patterns - 'Eye-catchers'
XVIII.g - Eye-catcher: Cement (pulmonary) embolism
II.b - ARDS - Acute lung injury V.b V - Pleural and/or pericardial involvement
V.b - Eosinophilic pleural effusion VI.h VI - Pulmonary vasculopathies
VI.h - Cement embolism VI.v VI - Pulmonary vasculopathies
VI.v - Foreign body/substance pulmonary embolism XI.b XI - Miscellaneous
XI.b - Chest pain (acute or subacute), lone or prominent XVIII.g XVIII - Distinctive patterns - 'Eye-catchers'
XVIII.g - Eye-catcher: Cement (pulmonary) embolism
1
Ethylene-vinyl alcohol copolymer (e.g. Onyx (R))
II.a
II - Pulmonary edema - Acute lung injury - ARDS
II.a - Pulmonary edema, noncardiogenic (NCPE) II.b II - Pulmonary edema - Acute lung injury - ARDS
II.b - ARDS - Acute lung injury II.f II - Pulmonary edema - Acute lung injury - ARDS
II.f - Hypoxemia, low oxygen saturation (may occur in isolation) VI.v VI - Pulmonary vasculopathies
VI.v - Foreign body/substance pulmonary embolism XI.l XI - Miscellaneous
XI.l - Superior vena cava syndrome
II.a - Pulmonary edema, noncardiogenic (NCPE) II.b II - Pulmonary edema - Acute lung injury - ARDS
II.b - ARDS - Acute lung injury II.f II - Pulmonary edema - Acute lung injury - ARDS
II.f - Hypoxemia, low oxygen saturation (may occur in isolation) VI.v VI - Pulmonary vasculopathies
VI.v - Foreign body/substance pulmonary embolism XI.l XI - Miscellaneous
XI.l - Superior vena cava syndrome
1
Hyaluronate - Hyaluronic acid
II.b
II - Pulmonary edema - Acute lung injury - ARDS
II.b - ARDS - Acute lung injury III.a III - Pulmonary/alveolar./airway hemorrhage/bleeding
III.a - Alveolar hemorrhage (AH), diffuse AH (DAH) VI.i VI - Pulmonary vasculopathies
VI.i - Acute pulmonary hypertension VI.v VI - Pulmonary vasculopathies
VI.v - Foreign body/substance pulmonary embolism XI.aa XI - Miscellaneous
XI.aa - CNS symptoms or involvement, stroke XII.g XII - Cardiovascular involvement / toxicity
XII.g - Coronary artery disease (acute) - Myocardial ischemia/infarction XV.ag XV - Pathology
XV.ag - Path: Foreign body embolism, microangiopathy, vasculopathy XVI.e XVI - Imaging
XVI.e - Imaging: Pulmonary opacities with a subpleural distribution
II.b - ARDS - Acute lung injury III.a III - Pulmonary/alveolar./airway hemorrhage/bleeding
III.a - Alveolar hemorrhage (AH), diffuse AH (DAH) VI.i VI - Pulmonary vasculopathies
VI.i - Acute pulmonary hypertension VI.v VI - Pulmonary vasculopathies
VI.v - Foreign body/substance pulmonary embolism XI.aa XI - Miscellaneous
XI.aa - CNS symptoms or involvement, stroke XII.g XII - Cardiovascular involvement / toxicity
XII.g - Coronary artery disease (acute) - Myocardial ischemia/infarction XV.ag XV - Pathology
XV.ag - Path: Foreign body embolism, microangiopathy, vasculopathy XVI.e XVI - Imaging
XVI.e - Imaging: Pulmonary opacities with a subpleural distribution
1
Transhepatic arterial chemoembolization (TACE)
I.b
I - Interstitial/parenchymal lung disease
I.b - Pneumonitis (ILD) I.c I - Interstitial/parenchymal lung disease
I.c - Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia) I.d I - Interstitial/parenchymal lung disease
I.d - Organizing pneumonia pattern (an area or areas of consolidation on imaging) I.e I - Interstitial/parenchymal lung disease
I.e - Acute eosinophilic pneumonia (AEP) I.y I - Interstitial/parenchymal lung disease
I.y - Progression, acceleration or exacerbation of preexisting ILD/fibrosis I.z I - Interstitial/parenchymal lung disease
I.z - An area or areas of consolidation II.b II - Pulmonary edema - Acute lung injury - ARDS
II.b - ARDS - Acute lung injury V.a V - Pleural and/or pericardial involvement
V.a - Pleural effusion (uni- or bilateral) (can accompany DI-LDs) VI.a VI - Pulmonary vasculopathies
VI.a - Pulmonary embolism - Venous thrombosis/thromboembolism VI.e VI - Pulmonary vasculopathies
VI.e - Fat/oil embolism - The FES embolism syndrome VI.v VI - Pulmonary vasculopathies
VI.v - Foreign body/substance pulmonary embolism VI.aa VI - Pulmonary vasculopathies
VI.aa - Lipiodol pulmonary embolism XI.aa XI - Miscellaneous
XI.aa - CNS symptoms or involvement, stroke XV.c XV - Pathology
XV.c - Path: Organizing pneumonia (OP/BOOP) pattern (see also Id) XVI.s XVI - Imaging
XVI.s - Imaging: An area or areas of involvement with high attenuation numbers or metallic density XVIII.h XVIII - Distinctive patterns - 'Eye-catchers'
XVIII.h - Eye-catcher: Lipiodol embolism
I.b - Pneumonitis (ILD) I.c I - Interstitial/parenchymal lung disease
I.c - Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia) I.d I - Interstitial/parenchymal lung disease
I.d - Organizing pneumonia pattern (an area or areas of consolidation on imaging) I.e I - Interstitial/parenchymal lung disease
I.e - Acute eosinophilic pneumonia (AEP) I.y I - Interstitial/parenchymal lung disease
I.y - Progression, acceleration or exacerbation of preexisting ILD/fibrosis I.z I - Interstitial/parenchymal lung disease
I.z - An area or areas of consolidation II.b II - Pulmonary edema - Acute lung injury - ARDS
II.b - ARDS - Acute lung injury V.a V - Pleural and/or pericardial involvement
V.a - Pleural effusion (uni- or bilateral) (can accompany DI-LDs) VI.a VI - Pulmonary vasculopathies
VI.a - Pulmonary embolism - Venous thrombosis/thromboembolism VI.e VI - Pulmonary vasculopathies
VI.e - Fat/oil embolism - The FES embolism syndrome VI.v VI - Pulmonary vasculopathies
VI.v - Foreign body/substance pulmonary embolism VI.aa VI - Pulmonary vasculopathies
VI.aa - Lipiodol pulmonary embolism XI.aa XI - Miscellaneous
XI.aa - CNS symptoms or involvement, stroke XV.c XV - Pathology
XV.c - Path: Organizing pneumonia (OP/BOOP) pattern (see also Id) XVI.s XVI - Imaging
XVI.s - Imaging: An area or areas of involvement with high attenuation numbers or metallic density XVIII.h XVIII - Distinctive patterns - 'Eye-catchers'
XVIII.h - Eye-catcher: Lipiodol embolism
2